Post-marketing Surveillance Study of the Effectiveness and Safety of new Oral Antivirals for outpatients with mild-moderate COVID-19. (ESOA-19)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  Drug prescriptions; Pharmacy dispensing records
• Data sources (types):
  Other
• Data sources (types), other:
  Prospective patient-based data collection, prescription event monitoring

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No